MREO (Mereo BioPharma Group) Float Percentage Of Total Shares Outstanding: 81.32% (As of Jul. 06, 2026)


MREO Mereo BioPharma Group PLC MREO
19 GF Score
Price $0.32
! 1 Warning Sign
View Full Analysis

What is Mereo BioPharma Group Float Percentage Of Total Shares Outstanding?

Mereo BioPharma Group MREO -5.41% 19 Float Percentage Of Total Shares Outstanding is 81.32% as of Jul. 06, 2026. GuruFocus rates MREO with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mereo BioPharma Group's float shares is 129.81 Mil. Mereo BioPharma Group's total shares outstanding is 159.62 Mil. Mereo BioPharma Group's float percentage of total shares outstanding is 81.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mereo BioPharma Group's Insider Ownership is 0.67%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mereo BioPharma Group's Institutional Ownership is 47.23%.

MREO
19GF Score
Mereo BioPharma Group PLC MREO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mereo BioPharma Group Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Mereo BioPharma Group's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=129.81/159.62
=81.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 81.32% mean?
Mereo BioPharma Group (MREO) has a Float Percentage Of Total Shares Outstanding of 81.32% as of Jul. 06, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Mereo BioPharma Group and its competitors.
Is Mereo BioPharma Group's Float Percentage Of Total Shares Outstanding too high?
Mereo BioPharma Group's current Float Percentage Of Total Shares Outstanding is 81.32%. Overall, Mereo BioPharma Group has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Mereo BioPharma Group's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Mereo BioPharma Group's Float Percentage Of Total Shares Outstanding of 81.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Mereo BioPharma Group and its competitors. Mereo BioPharma Group's current Float Percentage Of Total Shares Outstanding is 81.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mereo BioPharma Group stock overvalued right now?
Mereo BioPharma Group (MREO) has a current Float Percentage Of Total Shares Outstanding of 81.32%. The current Float Percentage Of Total Shares Outstanding is 81.32%. Mereo BioPharma Group's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Mereo BioPharma Group (MREO), the current Float Percentage Of Total Shares Outstanding is 81.32% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mereo BioPharma Group Business Description

Other Exchanges 0A9G:UKMAH0:Germany
Address One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
19GF Score

Get the complete analysis for MREO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price